The cGAS/STING signaling pathway: a cross-talk of infection, senescence and tumors

References

• Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity. 2016;44(4):739–754.
   PubMed Web of Science ®Google Scholar
• Evans MJ, Ni G, Ma Z, et al. cGAS and STING: At the intersection of DNA and RNA virus-sensing networks. PLoS Pathog. 2018;14(8):e1007148
   Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–820.
   PubMed Web of Science ®Google Scholar
• Couto D, Zipfel C. Regulation of pattern recognition receptor signalling in plants. Nat Rev Immunol. 2016;16(9):537–552.
   PubMed Web of Science ®Google Scholar
• Zhang X, Bai XC, Chen ZJ. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity. 2020;53(1):43–53.
   PubMed Web of Science ®Google Scholar
• Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. 2019;20(11):657–674.
   PubMed Web of Science ®Google Scholar
• Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science. 2019;363:6431.
   Web of Science ®Google Scholar
• Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat Immunol. 2016;17(10):1142–1149.
   PubMed Web of Science ®Google Scholar
• Kwon J, Bakhoum SF. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 2020;10(1):26–39.
   PubMed Web of Science ®Google Scholar
• Gentili M, Lahaye X, Nadalin F, et al. The N-terminal domain of cGAS determines preferential association with centromeric DNA and innate immune activation in the nucleus. Cell Rep. 2019;26(9):2377–2393.e2313. DOI:10.1016/j.celrep.2019.01.105
   PubMed Web of Science ®Google Scholar
• Michalski S, de Oliveira Mann CC, Stafford CA, et al. Structural basis for sequestration and autoinhibition of cGAS by chromatin. Nature. 2020;587(7835):678–682. DOI:10.1038/s41586-020-2748-0
   PubMed Web of Science ®Google Scholar
• Pathare GR, Decout A, Gluck S, et al. Structural mechanism of cGAS inhibition by the nucleosome. Nature. 2020;587(7835):668–672. DOI:10.1038/s41586-020-2750-6
   PubMed Web of Science ®Google Scholar
• Boyer JA, Spangler CJ, Strauss JD, et al. Structural basis of nucleosome-dependent cGAS inhibition. Science. 2020;370(6515):450–454. DOI:10.1126/science.abd0609
   PubMed Web of Science ®Google Scholar
• Kujirai T, Zierhut C, Takizawa Y, et al. Structural basis for the inhibition of cGAS by nucleosomes. Science. 2020;370(6515):455–458. DOI:10.1126/science.abd0237
   PubMed Web of Science ®Google Scholar
• Zhao B, Xu P, Rowlett CM, et al. The molecular basis of tight nuclear tethering and inactivation of cGAS. Nature. 2020;587(7835):673–677. DOI:10.1038/s41586-020-2749-z
   PubMed Web of Science ®Google Scholar
• Zhong L, Hu M-M, Bian L-J, et al. Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. Cell Discov. 2020;6(1). DOI:10.1038/s41421-020-0162-2
   Web of Science ®Google Scholar
• Zhang X, Wu J, Du F, et al. The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop. Cell Rep. 2014;6(3):421–430. DOI:10.1016/j.celrep.2014.01.003
   PubMed Web of Science ®Google Scholar
• Andreeva L, Hiller B, Kostrewa D, et al. cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders. Nature. 2017;549(7672):394–398. DOI:10.1038/nature23890
   PubMed Web of Science ®Google Scholar
• Zhou W, Whiteley AT, de Oliveira Mann CC, et al. Structure of the human cGAS–DNA complex reveals enhanced control of immune surveillance. Cell. 2018;174(2):300–311 e311. DOI:10.1016/j.cell.2018.06.026
   PubMed Web of Science ®Google Scholar
• Ablasser A, Goldeck M, Cavlar T, et al. cGAS produces a 2‘-5’-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013;498(7454):380–384. DOI:10.1038/nature12306
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi H, Wu J, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell. 2013;51(2):226–235. DOI:10.1016/j.molcel.2013.05.022
   PubMed Web of Science ®Google Scholar
• Du M, Chen ZJ. DNA-Induced liquid phase condensation of cGAS activates innate immune signaling. Science. 2018;361(6403):704–709.
   PubMed Web of Science ®Google Scholar
• Gao D, Li T, Li XD, et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc Natl Acad Sci USA. 2015;112(42):E5699–5705. DOI:10.1073/pnas.1516465112
   PubMed Web of Science ®Google Scholar
• Zhou W, Mohr L, Maciejowski J, et al. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Mol Cell. 2021;81(4):739–755 e737.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Dai T, He X, et al. The interactions between cGAS-STING pathway and pathogens. Signal Transduct Target Ther. 2020;5(1):91. DOI:10.1038/s41392-020-0198-7
   PubMed Web of Science ®Google Scholar
• Shang G, Zhu D, Li N, et al. Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP. Nat Struct Mol Biol. 2012;19(7):725–727. DOI:10.1038/nsmb.2332
   PubMed Web of Science ®Google Scholar
• Shu C, Yi G, Watts T, et al. Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system. Nat Struct Mol Biol. 2012;19(7):722–724.
   PubMed Web of Science ®Google Scholar
• Civril F, Deimling T, de Oliveira Mann CC, et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature. 2013;498(7454):332–337. DOI:10.1038/nature12305
   PubMed Web of Science ®Google Scholar
• Shang G, Zhang C, Chen ZJ, et al. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature. 2019;567(7748):389–393.
   PubMed Web of Science ®Google Scholar
• Dobbs N, Burnaevskiy N, Chen D, et al. STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe. 2015;18(2):157–168.
   PubMed Web of Science ®Google Scholar
• Gui X, Yang H, Li T, et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature. 2019;567(7747):262–266. DOI:10.1038/s41586-019-1006-9
   PubMed Web of Science ®Google Scholar
• Ran Y, Xiong MG, Xu ZS, et al. YIPF5 is essential for innate immunity to DNA virus and facilitates COPII-dependent STING trafficking. J Immunol. 2019;203(6):1560–1570.
   PubMed Web of Science ®Google Scholar
• B-C Z, Nandakumar R, Reinert LS, et al. STEEP mediates STING ER exit and activation of signaling. Nat Immunol. 2020;21(8):868–879. DOI:10.1038/s41590-020-0730-5
   PubMed Web of Science ®Google Scholar
• Almine JF, O’Hare CA, Dunphy G, et al. IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. Nat Commun. 2017;8(1):14392. DOI:10.1038/ncomms14392
   PubMedGoogle Scholar
• Nishikawa Y, Matsuzaki Y, Kimura K, et al. Modulation of stimulator of interferon genes (STING) expression by interferon-gamma in human keratinocytes. Biochem Genet. 2018;56(1–2):93–102.
   PubMed Web of Science ®Google Scholar
• Wang L, Wen M, Cao X. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science. 2019;365:6454.
   Web of Science ®Google Scholar
• Kwon D, Sesaki H, Kang SJ. Intracellular calcium is a rheostat for the STING signaling pathway. Biochem Biophys Res Commun. 2018;500(2):497–503.
   PubMed Web of Science ®Google Scholar
• Hou P, Lin Y, Li Z, et al. Autophagy receptor CCDC50 tunes the STING-mediated interferon response in viral infections and autoimmune diseases. Cell Mol Immunol. 2021;18(10):2358–2371. DOI:10.1038/s41423-021-00758-w
   PubMed Web of Science ®Google Scholar
• Li J, Bakhoum SF. Expanding the role of STING in cellular homeostasis and transformation. Trends Cancer. 2019;5(4):195–197.
   PubMed Web of Science ®Google Scholar
• Sun L, Wu J, Du F, et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786–791.
   PubMed Web of Science ®Google Scholar
• Prabakaran T, Bodda C, Krapp C, et al. Attenuation of cGAS-STING signaling is mediated by a p62/sqstm1-dependent autophagy pathway activated by TBK1. Embo J. 2018;37(8). DOI:10.15252/embj.201797858
   PubMed Web of Science ®Google Scholar
• Wu J, Sun L, Chen X, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339(6121):826–830. DOI:10.1126/science.1229963
   PubMed Web of Science ®Google Scholar
• Li T, Chen ZJ. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J Exp Med. 2018;215(5):1287–1299.
   PubMed Web of Science ®Google Scholar
• Schadt L, Sparano C, Schweiger NA, et al. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 2019;29(5):1236–1248 e1237. DOI:10.1016/j.celrep.2019.09.065
   PubMed Web of Science ®Google Scholar
• Woo SR, Fuertes MB, Corrales L, et al. STING-Dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41(5):830–842. DOI:10.1016/j.immuni.2014.10.017
   PubMed Web of Science ®Google Scholar
• Hu Z, Teng XL, Zhang T, et al. SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. Mol Cell. 2021;81(5):940–952 e945. DOI:10.1016/j.molcel.2020.12.024
   PubMed Web of Science ®Google Scholar
• Hodgins JJ, Khan ST, Park MM, et al. Killers 2.0: NK cell therapies at the forefront of cancer control. J Clin Invest. 2019;129(9):3499–3510.
   PubMed Web of Science ®Google Scholar
• Marcus A, Mao AJ, Lensink-Vasan M, et al. Tumor-Derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity. 2018;49(4):754–763.e754.
   PubMed Web of Science ®Google Scholar
• Takashima K, Takeda Y, Oshiumi H, et al. STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation. Biochem Biophys Res Commun. 2016;478(4):1764–1771. DOI:10.1016/j.bbrc.2016.09.021
   PubMed Web of Science ®Google Scholar
• Xia T, Konno H, Ahn J, et al. Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep. 2016;14(2):282–297.
   PubMed Web of Science ®Google Scholar
• Konno H, Yamauchi S, Berglund A, et al. Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. Oncogene. 2018;37(15):2037–2051.
   PubMed Web of Science ®Google Scholar
• Xia T, Konno H, Barber GN. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis. Cancer Res. 2016;76(22):6747–6759.
   PubMed Web of Science ®Google Scholar
• Wu L, Cao J, Cai WL, et al. KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018;16(8):e2006134. DOI:10.1371/journal.pbio.2006134
   PubMed Web of Science ®Google Scholar
• Kitajima S, Ivanova E, Guo S, et al. Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer. Cancer Discov. 2019;9(1):34–45. DOI:10.1158/2159-8290.CD-18-0689
   PubMed Web of Science ®Google Scholar
• Wu S, Zhang Q, Zhang F, et al. HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nat Cell Biol. 2019;21(8):1027–1040. DOI:10.1038/s41556-019-0352-z
   PubMed Web of Science ®Google Scholar
• Chen YA, Shen YL, Hsia HY, et al. Extrachromosomal telomere repeat DNA is linked to ALT development via cGAS-STING DNA sensing pathway. Nat Struct Mol Biol. 2017;24(12):1124–1131.
   PubMed Web of Science ®Google Scholar
• Li J, Duran MA, Dhanota N, et al. Metastasis and immune evasion from extracellular cGAMP hydrolysis. Cancer Discov. 2021;11(5):1212–1227. DOI:10.1158/2159-8290.CD-20-0387
   PubMed Web of Science ®Google Scholar
• Tan YS, Sansanaphongpricha K, Xie Y, et al. Mitigating SOX2-potentiated immune escape of head and neck squamous cell carcinoma with a STING-inducing nanosatellite vaccine. Clin Cancer Res. 2018;24(17):4242–4255. DOI:10.1158/1078-0432.CCR-17-2807
   PubMed Web of Science ®Google Scholar
• Mender I, Zhang A, Ren Z, et al. Telomere stress potentiates STING-dependent anti-tumor immunity. Cancer Cell. 2020;38(3):400–411 e406. DOI:10.1016/j.ccell.2020.05.020
   PubMed Web of Science ®Google Scholar
• Lioux T, Mauny MA, Lamoureux A, et al. Design, synthesis, and biological evaluation of novel cyclic adenosine-inosine monophosphate (cAIMP) analogs that activate stimulator of interferon genes (STING). J Med Chem. 2016;59(22):10253–10267. DOI:10.1021/acs.jmedchem.6b01300
   PubMed Web of Science ®Google Scholar
• Francica BJ, Ghasemzadeh A, Desbien AL, et al. TNFalpha and radioresistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in nonimmunogenic tumors. Cancer Immunol Res. 2018;6(4):422–433. DOI:10.1158/2326-6066.CIR-17-0263
   PubMed Web of Science ®Google Scholar
• Li T, Cheng H, Yuan H, et al. Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response. Sci Rep. 2016;6(1):19049. DOI:10.1038/srep19049
   PubMedGoogle Scholar
• Wang H, Hu S, Chen X, et al. cGAS is essential for the antitumor effect of immune checkpoint blockade. Proc Natl Acad Sci USA. 2017;114(7):1637–1642. DOI:10.1073/pnas.1621363114
   PubMed Web of Science ®Google Scholar
• Yang H, Lee WS, Kong SJ, et al. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade. J Clin Invest. 2019;129(10):4350–4364. DOI:10.1172/JCI125413
   PubMed Web of Science ®Google Scholar
• Fu J, Kanne DB, Leong M, et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci Transl Med. 2015;7(283):283ra252. DOI:10.1126/scitranslmed.aaa4306
   Web of Science ®Google Scholar
• Corrales L, Glickman LH, McWhirter SM, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11(7):1018–1030. DOI:10.1016/j.celrep.2015.04.031
   PubMed Web of Science ®Google Scholar
• Liu B, Tang L, Zhang X, et al. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists. Antiviral Res. 2017;147:37–46.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu B, Tang L, et al. Discovery and mechanistic study of a novel human-stimulator-of-interferon-genes agonist. ACS Infect Dis. 2019;5(7):1139–1149. DOI:10.1021/acsinfecdis.9b00010
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461(7265):788–792.
   PubMed Web of Science ®Google Scholar
• Hatano Y, Ideta T, Hirata A, et al. Virus-driven carcinogenesis. Cancers (Basel). 2021;13(11):2625. DOI:10.3390/cancers13112625
   PubMed Web of Science ®Google Scholar
• Guo F, Tang L, Shu S, et al. Activation of stimulator of interferon genes in hepatocytes suppresses the replication of hepatitis B virus. Antimicrob Agents Chemother. 2017;61(10). DOI:10.1128/AAC.00771-17
   Web of Science ®Google Scholar
• Lauterbach-Riviere L, Bergez M, Monch S, et al. Hepatitis B virus DNA is a substrate for the cGAS/STING pathway but is not sensed in infected hepatocytes. Viruses. 2020;12(6):592. DOI:10.3390/v12060592
   PubMed Web of Science ®Google Scholar
• Verrier ER, Yim SA, Heydmann L, et al. Hepatitis B virus evasion from cyclic guanosine monophosphate-adenosine monophosphate synthase sensing in human hepatocytes. Hepatology. 2018;68(5):1695–1709. DOI:10.1002/hep.30054
   PubMed Web of Science ®Google Scholar
• Hu J, Tang L, Cheng J, et al. Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases. Emerg Microbes Infect. 2021;10(1):852–864. DOI:10.1080/22221751.2021.1919034
   PubMed Web of Science ®Google Scholar
• Chen H, Jiang L, Chen S, et al. Hbx inhibits DNA sensing signaling pathway via ubiquitination and autophagy of cGAS. Virol J. 2022;19(1):55. DOI:10.1186/s12985-022-01785-3
   PubMed Web of Science ®Google Scholar
• Kim HR, Lee SH, Jung G. The hepatitis B viral X protein activates NF-kappaB signaling pathway through the up-regulation of TBK1. FEBS Lett. 2010;584(3):525–530.
   PubMed Web of Science ®Google Scholar
• Karakousis ND, Papatheodoridi A, Chatzigeorgiou A, et al. Cellular senescence and hepatitis B-related hepatocellular carcinoma: An intriguing link. Liver Int. 2020;40(12):2917–2927.
   PubMed Web of Science ®Google Scholar
• Lo Cigno I, Calati F, Albertini S, et al. Subversion of host innate immunity by human papillomavirus oncoproteins. Pathogens. 2020;9(4):292.
   PubMed Web of Science ®Google Scholar
• Bortnik V, Wu M, Julcher B, et al. Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells. J Microbiol Immunol Infect. 2021;54(4):733–739. DOI:10.1016/j.jmii.2020.07.010
   PubMedGoogle Scholar
• Lo Cigno I, Calati F, Borgogna C, et al. Human papillomavirus E7 oncoprotein subverts host innate immunity via SUV39H1-mediated epigenetic silencing of immune sensor genes. J Virol. 2020;94(4). DOI:10.1128/JVI.01812-19
   PubMed Web of Science ®Google Scholar
• Uhlorn BL, Jackson R, Li S, et al. Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection. PLoS Pathog. 2020;16(11):e1009028.
   PubMed Web of Science ®Google Scholar
• Lubbers JM, Koopman B, de Klerk-Sluis JM, et al. Association of homozygous variants of STING1 with outcome in human cervical cancer. Cancer Sci. 2021;112(1):61–71. DOI:10.1111/cas.14680
   PubMed Web of Science ®Google Scholar
• Huang S, Li R, Huang X, et al. Association study between methylation in the promoter regions of cGAS, MAVS, and TRAF3 genes and the risk of cervical precancerous lesions and cervical cancer in a southern Chinese population. Front Genet. 2019;10:1123.
   PubMed Web of Science ®Google Scholar
• Shi F, Su J, Wang J, et al. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response. Mol Cell Biochem. 2021;476(2):1015–1024.
   PubMed Web of Science ®Google Scholar
• Wang P, Deng Y, Guo Y, et al. Epstein-barr virus early protein BFRF1 suppresses IFN-beta activity by inhibiting the activation of IRF3. Front Immunol. 2020;11:513383.
   PubMed Web of Science ®Google Scholar
• Zhang G, Chan B, Samarina N, et al. Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS. Proc Natl Acad Sci USA. 2016;113(8):E1034–1043. DOI:10.1073/pnas.1516812113
   PubMed Web of Science ®Google Scholar
• Wu JJ, Li W, Shao Y, et al. Inhibition of cGAS DNA sensing by a herpesvirus virion protein. Cell Host Microbe. 2015;18(3):333–344. DOI:10.1016/j.chom.2015.07.015
   PubMed Web of Science ®Google Scholar
• Ma Z, Jacobs SR, West JA, et al. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. Proc Natl Acad Sci USA. 2015;112(31):E4306–4315. DOI:10.1073/pnas.1503831112
   PubMed Web of Science ®Google Scholar
• Lio CW, McDonald B, Takahashi M, et al. cGAS-STING signaling regulates initial innate control of cytomegalovirus infection. J Virol. 2016;90(17):7789–7797. DOI:10.1128/JVI.01040-16
   PubMed Web of Science ®Google Scholar
• Stempel M, Chan B, Juranic Lisnic V, et al. The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-kappaB signaling and STING’s dual role during MCMV infection. Embo J. 2019;38(5). DOI:10.15252/embj.2018100983
   PubMed Web of Science ®Google Scholar
• Leidal AM, Pringle ES, McCormick C. Evasion of oncogene-induced senescence by gammaherpesviruses. Curr Opin Virol. 2012;2(6):748–754.
   PubMed Web of Science ®Google Scholar
• Zhang LL, Wei JY, Wang L, et al. Human T-cell lymphotropic virus type 1 and its oncogenesis. Acta Pharmacol Sin. 2017;38(8):1093–1103.
   PubMed Web of Science ®Google Scholar
• Shudofsky AMD, Giam CZ. Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-kappaB hyperactivation-induced senescence. Blood Adv. 2019;3(4):564–569.
   PubMed Web of Science ®Google Scholar
• Giam CZ, Semmes OJ. HTLV-1 infection and adult T-cell leukemia/lymphoma—a tale of two proteins: tax and HBZ. Viruses. 2016;8(6):161.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang S, Liu L, et al. HTLV-1 tax impairs K63-linked ubiquitination of STING to evade host innate immunity. Virus Res. 2017;232:13–21.
   PubMed Web of Science ®Google Scholar
• Yuen CK, Chan CP, Fung SY, et al. Suppression of type I interferon production by human T-Cell leukemia virus type 1 oncoprotein tax through inhibition of IRF3 phosphorylation. J Virol. 2016;90(8):3902–3912. DOI:10.1128/JVI.00129-16
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966–972.
   PubMed Web of Science ®Google Scholar
• Coppe JP, Desprez PY, Krtolica A, et al. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol. 2010;5(1):99–118.
   PubMedGoogle Scholar
• Kuilman T, Michaloglou C, Vredeveld LC, et al. Oncogene-Induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133(6):1019–1031. DOI:10.1016/j.cell.2008.03.039
   PubMed Web of Science ®Google Scholar
• Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):2853–2868. DOI:10.1371/journal.pbio.0060301
   PubMed Web of Science ®Google Scholar
• Loo TM, Miyata K, Tanaka Y, et al. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer. Cancer Sci. 2020;111(2):304–311.
   PubMed Web of Science ®Google Scholar
• Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34(23–24):1565–1576.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Okada R, Nagao K, et al. Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat Commun. 2017;8(1):15287. DOI:10.1038/ncomms15287
   PubMedGoogle Scholar
• Zhao M, Wang F, Wu J, et al. CGAS is a micronucleophagy receptor for the clearance of micronuclei. Autophagy. 2021;17(12):3976–3991.
   PubMed Web of Science ®Google Scholar
• Vizioli MG, Liu T, Miller KN, et al. Mitochondria-To-Nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence. Genes Dev. 2020;34(5–6):428–445. DOI:10.1101/gad.331272.119
   PubMed Web of Science ®Google Scholar
• Takahashi A, Loo TM, Okada R, et al. Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells. Nat Commun. 2018;9(1):1249. DOI:10.1038/s41467-018-03555-8
   PubMedGoogle Scholar
• Han X, Chen H, Gong H, et al. Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress-induced senescence. J Biol Chem. 2020;295(14):4451–4463. DOI:10.1074/jbc.RA119.010734
   PubMed Web of Science ®Google Scholar
• Yang H, Wang H, Ren J, et al. cGAS is essential for cellular senescence. Proc Natl Acad Sci USA. 2017;114(23):E4612–E4620.
   PubMed Web of Science ®Google Scholar
• Gluck S, Guey B, Gulen MF, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol. 2017;19(9):1061–1070. DOI:10.1038/ncb3586
   PubMed Web of Science ®Google Scholar
• Dou Z, Ghosh K, Vizioli MG, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550(7676):402–406. DOI:10.1038/nature24050
   PubMed Web of Science ®Google Scholar
• Sieben CJ, Sturmlechner I, van de Sluis B, et al. Two-step senescence-focused cancer therapies. Trends Cell Biol. 2018;28(9):723–737.
   PubMed Web of Science ®Google Scholar
• Milanovic M, Fan DNY, Belenki D, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553(7686):96–100. DOI:10.1038/nature25167
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi YW, Lee J, et al. Senescent tumor cells lead the collective invasion in thyroid cancer. Nat Commun. 2017;8(1):15208.
   PubMedGoogle Scholar
• Cleal K, Baird DM. Catastrophic endgames: emerging mechanisms of telomere-driven genomic instability. Trends Genet. 2020;36(5):347–359.
   PubMed Web of Science ®Google Scholar
• Victorelli S, Lagnado A, Halim J, et al. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. Embo J. 2019;38(23):e101982. DOI:10.15252/embj.2019101982
   PubMed Web of Science ®Google Scholar
• Freund A, Orjalo AV, Desprez PY, et al. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16(5):238–246.
   PubMed Web of Science ®Google Scholar
• Abdisalaam S, Bhattacharya S, Mukherjee S, et al. Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase. J Biol Chem. 2020;295(32):11144–11160. DOI:10.1074/jbc.RA120.012962
   PubMed Web of Science ®Google Scholar
• Innes AJ, Gil J. IMR90 ER:RAS: a cell model of oncogene-induced senescence. Methods Mol Biol. 2019;1896:83–92.
   PubMedGoogle Scholar
• Aird KM, Zhang R. Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett. 2015;356(2 Pt A):204–210.
   PubMed Web of Science ®Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, et al. Oncogene-Induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444(7119):638–642. DOI:10.1038/nature05327
   PubMed Web of Science ®Google Scholar
• Dunphy G, Flannery SM, Almine JF, et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-κB signaling after nuclear DNA damage. Mol Cell. 2018;71(5):745–760.e745. DOI:10.1016/j.molcel.2018.07.034
   PubMed Web of Science ®Google Scholar
• Hari P, Millar FR, Tarrats N, et al. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Sci Adv. 2019;5(6):eaaw0254. DOI:10.1126/sciadv.aaw0254
   PubMed Web of Science ®Google Scholar
• Leon KE, Buj R, Lesko E, et al. DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A. J Cell Biol. 2021;220(8). DOI:10.1083/jcb.202008101
   PubMed Web of Science ®Google Scholar
• Barroso-Vilares M, Logarinho E. Chromosomal instability and pro-inflammatory response in aging. Mech Ageing Dev. 2019;182:111118.
   PubMed Web of Science ®Google Scholar
• Bakhoum SF, Ngo B, Laughney AM, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553(7689):467–472. DOI:10.1038/nature25432
   PubMed Web of Science ®Google Scholar
• Fenech M. Cytokinesis-block micronucleus cytome assay evolution into a more comprehensive method to measure chromosomal instability. Genes (Basel). 2020;11(10):1203.
   PubMed Web of Science ®Google Scholar
• Lewis CW, Golsteyn RM. Cancer cells that survive checkpoint adaptation contain micronuclei that harbor damaged DNA. Cell Cycle. 2016;15(22):3131–3145.
   PubMed Web of Science ®Google Scholar
• Kalsbeek D, Golsteyn RM. G2/M-phase checkpoint adaptation and micronuclei formation as mechanisms that contribute to genomic instability in human cells. Int J Mol Sci. 2017;18(11):2344.
   PubMed Web of Science ®Google Scholar
• Harding SM, Benci JL, Irianto J, et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature. 2017;548(7668):466–470.
   PubMed Web of Science ®Google Scholar
• Bakhoum MF, Francis JH, Agustinus A, et al. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nat Commun. 2021;12(1):5402. DOI:10.1038/s41467-021-25529-z
   PubMed Web of Science ®Google Scholar
• Gratia M, Rodero MP, Conrad C, et al. Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS. J Exp Med. 2019;216(5):1199–1213. DOI:10.1084/jem.20181329
   PubMed Web of Science ®Google Scholar
• Yan-Fei H, Han Y, Yan-Ting Z, et al. Dysregulation in nucleic acid-sensing pathway genes is associated with cancer patients’ prognosis. Cancer Sci. 2020;111(7):2212–2222. DOI:10.1111/cas.14450
   PubMed Web of Science ®Google Scholar
• An X, Zhu Y, Zheng T, et al. An analysis of the expression and association with immune cell infiltration of the cGAS/STING pathway in pan-cancer. Mol Ther Nucleic Acids. 2019;14:80–89.
   PubMedGoogle Scholar
• Lemos H, Mohamed E, Huang L, et al. STING promotes the growth of tumors characterized by low antigenicity via IDO activation. Cancer Res. 2016;76(8):2076–2081. DOI:10.1158/0008-5472.CAN-15-1456
   PubMed Web of Science ®Google Scholar
• Ahn J, Xia T, Konno H, et al. Inflammation-driven carcinogenesis is mediated through STING. Nat Commun. 2014;5(1):5166.
   PubMedGoogle Scholar
• Chen Q, Boire A, Jin X, et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 2016;533(7604):493–498. DOI:10.1038/nature18268
   PubMed Web of Science ®Google Scholar
• Cao Y, Yao M, Wu Y, et al. N-acetyltransferase 10 promotes micronuclei formation to activate the senescence-associated secretory phenotype machinery in colorectal cancer cells. Transl Oncol. 2020;13(8):100783.
   PubMed Web of Science ®Google Scholar
• Gorgoulis V, Adams PD, Alimonti A, et al. Cellular senescence: defining a path forward. Cell. 2019;179(4):813–827. DOI:10.1016/j.cell.2019.10.005
   PubMed Web of Science ®Google Scholar